Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 17 | 2020 | 96 | 6.460 |
Why?
|
| Device Removal | 18 | 2020 | 161 | 4.710 |
Why?
|
| Vena Cava, Inferior | 12 | 2022 | 143 | 4.300 |
Why?
|
| Pulmonary Embolism | 10 | 2020 | 222 | 2.460 |
Why?
|
| Prosthesis Implantation | 5 | 2020 | 125 | 2.340 |
Why?
|
| Venous Thrombosis | 8 | 2022 | 243 | 1.740 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2023 | 384 | 1.620 |
Why?
|
| Liver Neoplasms | 7 | 2023 | 736 | 1.550 |
Why?
|
| Chemoembolization, Therapeutic | 2 | 2022 | 36 | 1.340 |
Why?
|
| Catheter Ablation | 2 | 2022 | 233 | 1.160 |
Why?
|
| Treatment Outcome | 29 | 2023 | 7993 | 1.010 |
Why?
|
| Radiography, Interventional | 9 | 2019 | 150 | 0.920 |
Why?
|
| Embolization, Therapeutic | 8 | 2023 | 238 | 0.780 |
Why?
|
| Cholecystostomy | 1 | 2020 | 3 | 0.770 |
Why?
|
| Cholecystitis, Acute | 1 | 2020 | 7 | 0.770 |
Why?
|
| Surgical Instruments | 1 | 2020 | 57 | 0.730 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 35 | 0.730 |
Why?
|
| Phlebography | 7 | 2017 | 66 | 0.730 |
Why?
|
| Prosthesis Design | 8 | 2019 | 278 | 0.710 |
Why?
|
| Renal Dialysis | 6 | 2007 | 355 | 0.670 |
Why?
|
| Aorta | 1 | 2020 | 280 | 0.670 |
Why?
|
| Liver Transplantation | 7 | 2013 | 1268 | 0.660 |
Why?
|
| Stents | 3 | 2013 | 377 | 0.640 |
Why?
|
| Hemorrhage | 1 | 2019 | 268 | 0.610 |
Why?
|
| Retrospective Studies | 19 | 2023 | 8489 | 0.610 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 469 | 0.560 |
Why?
|
| Jugular Veins | 2 | 2014 | 69 | 0.560 |
Why?
|
| Femoral Vein | 2 | 2014 | 35 | 0.560 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 218 | 0.550 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2006 | 40 | 0.540 |
Why?
|
| Microwaves | 1 | 2014 | 34 | 0.510 |
Why?
|
| Vena Cava, Superior | 3 | 2014 | 59 | 0.510 |
Why?
|
| Vascular Diseases | 2 | 2014 | 121 | 0.500 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 33 | 0.480 |
Why?
|
| Catheters, Indwelling | 4 | 2013 | 110 | 0.480 |
Why?
|
| Middle Aged | 27 | 2021 | 25028 | 0.480 |
Why?
|
| Catheterization, Central Venous | 3 | 2013 | 116 | 0.460 |
Why?
|
| Humans | 52 | 2023 | 86643 | 0.450 |
Why?
|
| Cholangiocarcinoma | 2 | 2023 | 66 | 0.440 |
Why?
|
| Bile Duct Neoplasms | 2 | 2023 | 79 | 0.440 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 6509 | 0.420 |
Why?
|
| Aged | 18 | 2021 | 18415 | 0.410 |
Why?
|
| Yttrium Radioisotopes | 5 | 2023 | 46 | 0.410 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 69 | 0.400 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.400 |
Why?
|
| Thrombectomy | 4 | 2022 | 158 | 0.390 |
Why?
|
| Iliac Vein | 1 | 2011 | 30 | 0.390 |
Why?
|
| Female | 30 | 2021 | 44532 | 0.390 |
Why?
|
| Portal Vein | 2 | 2013 | 120 | 0.390 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 43 | 0.390 |
Why?
|
| Bariatric Surgery | 2 | 2011 | 194 | 0.380 |
Why?
|
| Hepatic Artery | 3 | 2021 | 83 | 0.380 |
Why?
|
| Male | 29 | 2021 | 40965 | 0.360 |
Why?
|
| Hepatic Duct, Common | 1 | 2009 | 9 | 0.360 |
Why?
|
| Biliary Fistula | 1 | 2009 | 11 | 0.350 |
Why?
|
| Time Factors | 8 | 2019 | 5210 | 0.350 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 71 | 0.350 |
Why?
|
| Angioplasty, Balloon | 2 | 2007 | 95 | 0.350 |
Why?
|
| Anticoagulants | 5 | 2020 | 408 | 0.330 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 153 | 0.320 |
Why?
|
| Adult | 18 | 2021 | 25648 | 0.320 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 225 | 0.320 |
Why?
|
| Liver Cirrhosis | 2 | 2009 | 297 | 0.310 |
Why?
|
| Chicago | 3 | 2019 | 1379 | 0.300 |
Why?
|
| Arm | 1 | 2007 | 91 | 0.300 |
Why?
|
| Aneurysm, False | 3 | 2013 | 54 | 0.270 |
Why?
|
| Ischemia | 1 | 2007 | 243 | 0.270 |
Why?
|
| Thrombolytic Therapy | 3 | 2020 | 220 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 208 | 0.260 |
Why?
|
| Postoperative Complications | 5 | 2013 | 2207 | 0.250 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 111 | 0.240 |
Why?
|
| Risk Factors | 4 | 2019 | 5417 | 0.240 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 3640 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2021 | 2601 | 0.220 |
Why?
|
| Constriction, Pathologic | 5 | 2022 | 213 | 0.220 |
Why?
|
| Cholangiography | 2 | 2005 | 41 | 0.210 |
Why?
|
| Propensity Score | 1 | 2022 | 136 | 0.210 |
Why?
|
| Bile | 1 | 2001 | 57 | 0.200 |
Why?
|
| Fistula | 1 | 2021 | 42 | 0.200 |
Why?
|
| Tokyo | 1 | 2020 | 3 | 0.190 |
Why?
|
| Adolescent | 9 | 2021 | 8981 | 0.190 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 15 | 0.190 |
Why?
|
| Vascular Patency | 5 | 2022 | 126 | 0.180 |
Why?
|
| Brachytherapy | 1 | 2021 | 119 | 0.180 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 37 | 0.180 |
Why?
|
| Hypotension | 1 | 2020 | 70 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2019 | 24 | 0.180 |
Why?
|
| Catheterization | 3 | 2008 | 232 | 0.180 |
Why?
|
| Equipment Safety | 2 | 2011 | 31 | 0.170 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.170 |
Why?
|
| Renal Veins | 2 | 2017 | 28 | 0.170 |
Why?
|
| Radiation Dosage | 1 | 2019 | 227 | 0.170 |
Why?
|
| Anesthesia, General | 1 | 2019 | 114 | 0.170 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2023 | 70 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 134 | 0.160 |
Why?
|
| Radiography | 4 | 2013 | 813 | 0.160 |
Why?
|
| Young Adult | 5 | 2021 | 5976 | 0.160 |
Why?
|
| Length of Stay | 1 | 2020 | 702 | 0.150 |
Why?
|
| Recurrence | 1 | 2020 | 1139 | 0.150 |
Why?
|
| Pipecolic Acids | 2 | 2006 | 14 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2013 | 2261 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 971 | 0.140 |
Why?
|
| Fluoroscopy | 1 | 2016 | 119 | 0.140 |
Why?
|
| Anastomosis, Surgical | 2 | 2009 | 267 | 0.140 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2007 | 99 | 0.140 |
Why?
|
| Thrombin | 2 | 2013 | 61 | 0.130 |
Why?
|
| Hemostatics | 2 | 2013 | 56 | 0.130 |
Why?
|
| Angioplasty | 2 | 2013 | 70 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 131 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1801 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2006 | 229 | 0.120 |
Why?
|
| Microspheres | 2 | 2023 | 101 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2013 | 70 | 0.110 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 39 | 0.110 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 34 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2013 | 63 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 92 | 0.110 |
Why?
|
| Endoleak | 1 | 2012 | 35 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2011 | 751 | 0.100 |
Why?
|
| Contraindications | 1 | 2011 | 72 | 0.100 |
Why?
|
| Child, Preschool | 5 | 2006 | 3612 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 112 | 0.100 |
Why?
|
| Survival Rate | 1 | 2014 | 1863 | 0.090 |
Why?
|
| Plasma | 2 | 2007 | 50 | 0.090 |
Why?
|
| Equipment Design | 1 | 2011 | 406 | 0.090 |
Why?
|
| Renal Artery | 1 | 2010 | 64 | 0.090 |
Why?
|
| Portal System | 1 | 2009 | 13 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 27 | 0.090 |
Why?
|
| Liver Failure | 1 | 2009 | 78 | 0.080 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 107 | 0.080 |
Why?
|
| Contrast Media | 3 | 2013 | 1078 | 0.080 |
Why?
|
| Alloys | 1 | 2007 | 10 | 0.080 |
Why?
|
| Axillary Vein | 1 | 2007 | 5 | 0.080 |
Why?
|
| Nephrectomy | 1 | 2010 | 294 | 0.080 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.080 |
Why?
|
| Hemostasis | 1 | 2007 | 21 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2009 | 238 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2011 | 770 | 0.080 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2006 | 9 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2007 | 45 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2007 | 91 | 0.070 |
Why?
|
| Thrombosis | 2 | 2006 | 296 | 0.070 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2006 | 33 | 0.070 |
Why?
|
| Dilatation | 1 | 2006 | 48 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 58 | 0.070 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2006 | 5 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2006 | 96 | 0.070 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 29 | 0.070 |
Why?
|
| Bacteremia | 1 | 2007 | 99 | 0.070 |
Why?
|
| Potassium | 5 | 1990 | 281 | 0.070 |
Why?
|
| Microfluidics | 1 | 2006 | 51 | 0.070 |
Why?
|
| Angiography | 2 | 2021 | 208 | 0.070 |
Why?
|
| Spasm | 1 | 2005 | 16 | 0.070 |
Why?
|
| Nitroglycerin | 1 | 2005 | 22 | 0.070 |
Why?
|
| Graft Survival | 1 | 2009 | 884 | 0.070 |
Why?
|
| Punctures | 1 | 2005 | 29 | 0.070 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 34 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 152 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 621 | 0.060 |
Why?
|
| Retreatment | 2 | 2021 | 107 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 255 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 594 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2360 | 0.060 |
Why?
|
| Necrosis | 1 | 2023 | 204 | 0.060 |
Why?
|
| Venous Pressure | 1 | 2002 | 11 | 0.050 |
Why?
|
| Leiomyoma | 1 | 2005 | 191 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 746 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 227 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2001 | 25 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2001 | 58 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 228 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1851 | 0.050 |
Why?
|
| Drainage | 1 | 2001 | 157 | 0.050 |
Why?
|
| Erythrocyte Membrane | 2 | 1990 | 60 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2002 | 710 | 0.040 |
Why?
|
| Erythrocytes | 2 | 1989 | 255 | 0.040 |
Why?
|
| Infant | 3 | 2013 | 3046 | 0.040 |
Why?
|
| Arginine | 2 | 2006 | 136 | 0.030 |
Why?
|
| Chlorides | 3 | 1989 | 103 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2006 | 300 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1565 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2005 | 92 | 0.030 |
Why?
|
| Child | 4 | 2006 | 6927 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 117 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 285 | 0.030 |
Why?
|
| Sodium | 2 | 1990 | 341 | 0.030 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1989 | 12 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 943 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1577 | 0.020 |
Why?
|
| Ion Channels | 1 | 1990 | 246 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1991 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1989 | 131 | 0.020 |
Why?
|
| Phospholipids | 1 | 2007 | 111 | 0.020 |
Why?
|
| Hemofiltration | 1 | 2006 | 11 | 0.020 |
Why?
|
| Duodenum | 1 | 2007 | 100 | 0.020 |
Why?
|
| Titrimetry | 1 | 2006 | 15 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2007 | 149 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2006 | 68 | 0.020 |
Why?
|
| Life Tables | 1 | 2005 | 48 | 0.020 |
Why?
|
| Ointments | 1 | 2005 | 12 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 47 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2007 | 110 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 429 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 58 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2705 | 0.020 |
Why?
|
| Femur | 1 | 2005 | 116 | 0.020 |
Why?
|
| Arteries | 1 | 2005 | 176 | 0.020 |
Why?
|
| Biological Transport | 3 | 1989 | 396 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 162 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1313 | 0.010 |
Why?
|
| Reoperation | 1 | 2005 | 597 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 509 | 0.010 |
Why?
|
| Phlebotomy | 1 | 2001 | 21 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 2001 | 35 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 2379 | 0.010 |
Why?
|
| Veins | 1 | 2001 | 94 | 0.010 |
Why?
|
| United States | 1 | 2013 | 6672 | 0.010 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1989 | 3 | 0.010 |
Why?
|
| Methazolamide | 2 | 1989 | 3 | 0.010 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1989 | 17 | 0.010 |
Why?
|
| Sheep | 2 | 1990 | 239 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 695 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 493 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1990 | 119 | 0.010 |
Why?
|
| Cations | 1 | 1989 | 30 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1989 | 144 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 112 | 0.010 |
Why?
|
| Permeability | 1 | 1989 | 137 | 0.010 |
Why?
|
| Hemoglobin SC Disease | 1 | 1989 | 1 | 0.010 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1989 | 4 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1989 | 66 | 0.010 |
Why?
|
| Dogs | 1 | 1990 | 685 | 0.010 |
Why?
|
| Bumetanide | 1 | 1988 | 3 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1989 | 401 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1990 | 435 | 0.010 |
Why?
|
| Anions | 1 | 1988 | 31 | 0.010 |
Why?
|
| Ouabain | 1 | 1988 | 24 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1988 | 102 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 181 | 0.010 |
Why?
|
| Hemolysis | 1 | 1988 | 61 | 0.010 |
Why?
|
| Furosemide | 1 | 1988 | 33 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 636 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 989 | 0.000 |
Why?
|
| Kinetics | 1 | 1988 | 1513 | 0.000 |
Why?
|
| Calcium | 1 | 1989 | 1156 | 0.000 |
Why?
|
| Animals | 2 | 1990 | 26582 | 0.000 |
Why?
|